Mode
Text Size
Log in / Sign up
N/A N=402 Randomized Single-blind Supportive Care

Indiana Palliative Excellence in Alzheimer's Care Efforts

Dementia

Enrolled (actual)
402
Serious AEs
55.2%
Results posted
May 2024
Primary outcome: Primary: Neuropsychiatric Inventory Questionnaire (NPI-Q) for Patient Symptom and Severity — 9.149; 9.39 score on a scale — p=0.8719

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
IN-PEACE Dementia Care Coordination (Behavioral)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
Indiana University
Primary completion
Jan 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Neuropsychiatric Inventory Questionnaire (NPI-Q) for Patient Symptom and Severity
9.149; 9.39 0.8719
SECONDARY
Symptom Management - End of Life for Dementia (SM-EOLD)
28.36; 26.133 0.8389
SECONDARY
Patient Health Questionnaire (PHQ-8) Caregiver
4.472; 4.522 0.3431
SECONDARY
Neuropsychiatric Inventory Questionnaire (NPI-Q) Caregiver Distress
9.282; 10.148 0.6612
SECONDARY
Emergency Department Visits and Hospitalizations
50; 80 0.0007 sig

Summary

The overarching goal of this research is to improve the care of community dwelling patients with dementia and their family caregivers through an innovative model of supportive care that combines an existing, evidence-based intervention for dementia care with an innovative intervention for palliative care in dementia. The intervention projects this care into the homes of patients and caregivers, empowering caregivers, and integrating with ongoing care. IN-PEACE will enroll 200 patient-caregiver dyads, randomizing 100 dyads each to the intervention and usual care arms and follow for 24 months with quarterly outcome assessments. The core of the multi-component intervention is regular, proactive telephone contact by a dementia care coordinator (DCC; social worker or RN) to anticipate and identify patients' symptoms and caregivers needs and address by utilizing specific, evidence-based protocols. Protocols cover basic dementia care, caregiver distress, neuropsychiatric symptoms, pain, navigating the hospital, feeding difficulties, and transition to hospice. The intervention also involves advance care planning and support with caregivers tailored to decisions faced in dementia care, highlighting where palliative care options can replace the default that often results in burdensome treatments. The primary aim of IN-PEACE is to test the effect of the intervention on patients' neuropsychiatric symptoms. Other aims include testing the effect of IN-PEACE on patients' overall symptom outcomes, caregiver mood and distress, and the provision of burdensome treatments to patients (hospitalizations and emergency room visits).

Eligibility Criteria

Inclusion Criteria: Community-dwelling and living in the Indianapolis metropolitan area; Patient with an established diagnosis of dementia of any etiology; Dementia in the moderate (FAST stage 5) to severe stage (FAST 6-7); and English-speaking Primary caregiver informant enrolled in study. Exclusion Criteria: Patient with dementia residing in a nursing facility or receiving hospice care; Patient or Caregiver with long-standing history of severe mental illness or Psychiatric disorder preexisting the dementia diagnosis. Initially, non-English speaking patients were excluded. On April 14, 2020, Institutional Review Board (IRB) Amendment eliminated this exclusion so non-English speaking patients could be enrolled as long as their Caregiver was English-speaking and able to complete assessments.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03773757). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search